Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Scientific Reports|January 21, 2026
Genome-wide screens identify core regulators of cell surface prion protein expressionKathryn S Beauchemin, Surachai SupattaponeBiorxiv : the Preprint Server for Biology|December 22, 2025
Genome-Wide Screens Identify Core Regulators of Cell Surface Prion Protein ExpressionKathryn S Beauchemin, Surachai SupattaponeThe Journal of General Virology|December 14, 2021
Alternating anti-prion regimens reduce combination drug resistance but do not further extend survival in scrapie-infected miceKathryn S Beauchemin, Judy R Rees, Surachai SupattaponeJournal of Cell Science|February 24, 2021
SEC24A facilitates colocalization and Ca2+ flux between the endoplasmic reticulum and mitochondriaTamutenda Chidawanyika, Rajarshi Chakrabarti, Kathryn S Beauchemin, et al.Plos Pathogens|January 8, 2024
Correction: Emergence of Prions Selectively Resistant to Combination Drug TherapyCassandra M Burke, Kenneth M K Mark, Judit Kun, et al.Plos Pathogens|May 19, 2020
Emergence of prions selectively resistant to combination drug therapyCassandra M Burke, Kenneth M K Mark, Judit Kun, et al.ACS Combinatorial Science|June 24, 2020
Combinatorial Resurfacing of Dengue Envelope Protein Domain III Antigens Selectively Ablates Epitopes Associated with Serotype-Specific or Infection-Enhancing Antibody ResponsesJennifer L Remmel, Kathryn S Beauchemin, Akaash K Mishra, et al.Plos Pathogens|January 12, 2026
Oligosaccharyltransferase (OST) complex inhibition effectively treats rodent and human prionsKathryn S Beauchemin, Judit Kun, Bradley Groveman, et al.Biorxiv : the Preprint Server for Biology|February 23, 2026
Convergent strategies for nanobody-mediated inhibition of an epoxide hydrolaseAdam R Simard, Noor M Taher, Kathryn S Beauchemin, et al.Pageof 1